Morrissey v HSE [2020] IESC 6 — The Five-Issue Supreme Court Decision That Anchors Irish Medical Negligence Law in 2026

The Facts of Morrissey v HSE Copy link

Ruth Morrissey, a mother of one from Co. Limerick, had a cervical smear test in August 2009 reported by Quest Diagnostics Incorporated (a US laboratory in Grand Rapids, Michigan contracted to read CervicalCheck samples). She had a further smear in August 2012 reported by Medlab Pathology Limited (an Irish laboratory in Sandyford, Dublin 18). Both reports were returned as negative. In May 2014, Mrs Morrissey attended her GP following symptomatic bleeding and was referred for further testing. A biopsy and an MRI scan disclosed the existence of cervical cancer, and she underwent treatment.

Subsequent CervicalCheck audits in 2014 and 2015 re-examined the earlier slides. Both the 2009 Quest slide and the 2012 Medlab slide were found, on re-examination, to contain abnormalities that should have been identified at the time. Mrs Morrissey was not told of those audit findings until May 2018 — almost four years after the audits were completed and only after the public CervicalCheck disclosure controversy triggered by Vicky Phelan's settlement on 25 April 2018.

By 2018 the cancer had recurred. Mrs Morrissey and her husband Paul issued proceedings against the HSE, Quest, and Medlab in the High Court. The trial before Mr Justice Kevin Cross ran for 36 days. On 3 May 2019 Cross J delivered judgment in Morrissey v HSE [2019] IEHC 268, awarding the Morrisseys €2,152,508 plus €10,000 in nominal damages against the HSE for failure to disclose the audit findings. Mrs Morrissey died on 19 July 2020, four months after the Supreme Court decision. Mr Morrissey continued the appeal.

Mrs Morrissey was not the only woman affected. The Scoping Inquiry into the CervicalCheck Screening Programme led by Dr Gabriel Scally and the HSE's own subsequent disclosures established that at least 221 women in the audit cohort had received negative smear reports that later audit found to be incorrect — the figure from which the "221+" Patient Support Group, founded in July 2018 by Stephen Teap, Lorraine Walsh and Vicky Phelan, takes its name. Eighteen of those women had died before the disclosure failures became public in 2018. Morrissey therefore reaches the Supreme Court as one named litigant's case against a backdrop of systemic failure in cytology reporting and audit-disclosure practice.

The Legal Question — Five Issues for the Supreme Court Copy link

The Supreme Court identified five distinct questions to resolve: the legal standard for a cytology screener; the sufficiency of the trial judge's reasoning on the Quest slide; the same question for the Medlab slide; the HSE's liability for the laboratories; and the appropriate damages award.

The five-judge Court (Clarke CJ, with O'Donnell J, McKechnie J, Dunne J, and O'Malley J concurring) heard a leapfrog appeal direct from the High Court under Article 34.5.4° of the Constitution, on the basis that the issues were of general public importance. The leapfrog provision — introduced by the Thirty-third Amendment of the Constitution Act 2013, which restructured Irish appellate jurisdiction — allows a direct appeal from the High Court to the Supreme Court, bypassing the Court of Appeal, where the Supreme Court is satisfied that the decision involves a matter of general public importance or that an appeal is necessary in the interests of justice. The leave-to-appeal determination is reported as Morrissey v HSE [2019] IESC 60. The leapfrog route is exceptional; its use in Morrissey reflects how the Supreme Court viewed the broader public-health and doctrinal significance of the CervicalCheck dispute. Each of the five questions the Court resolved is set out below.

1. Standard of approach — what legal standard governs a cytology screener reading a cervical smear, and did the trial judge wrongly impose an "absolute confidence" test?
2. Sufficiency of reasoning regarding Quest — did Cross J give adequate reasons for finding the Quest screening of the 2009 slide negligent?
3. Sufficiency of reasoning regarding Medlab — did Cross J give adequate reasons for finding the Medlab screening of the 2012 slide negligent?
4. HSE liability — was the HSE vicariously liable for the laboratories' negligence, or alternatively did it owe a non-delegable duty to women participating in CervicalCheck?
5. Damages — was the €500,000 general damages award too high (or alternatively the appropriate cap), and was the High Court's separate award to Mr Morrissey for the value of future services his wife would have provided lawful?

The Court's Decision — How the Five Issues Were Resolved Copy link

The Supreme Court dismissed the central HSE and laboratory appeals, allowed Medlab's narrow appeal on the loss-of-services award, and produced what remains the most consequential medical-negligence judgment in Ireland of the past decade. Each issue is addressed below with the relevant pinpoint citation.

Issue 1 — Standard of Approach and the Dunne Test Copy link

The Court reaffirmed that the test for medical negligence in Ireland is, and remains, the six-principle test from Dunne v National Maternity Hospital [1989] IR 91 — the formulation of Finlay CJ:

"The true test for establishing negligence in diagnosis or treatment on the part of a medical practitioner is whether he has been proved to be guilty of such failure as no medical practitioner of equal specialist or general status and skill would be guilty of if acting with ordinary care."

Finlay CJ in Dunne v National Maternity Hospital [1989] IR 91 at p.109, reaffirmed by Clarke CJ in Morrissey v HSE [2020] IESC 6

That standard is not satisfied merely because a different practitioner would have acted differently. The Dunne formulation is in fact a set of six interlocking principles set out by Finlay CJ at p.109 of the report, sometimes summarised in modern practice as five operative principles plus an evidential rider on approved practice:

1. The general professional standard. A practitioner is not negligent merely because a different practitioner would have done something different; the question is whether no practitioner of equal status and skill would have done the same.
2. Deviation from approved general and approved practice is not in itself negligent unless the practice in question was so inherently defective that no practitioner of equal status and skill would have followed it.
3. Compliance with approved general and approved practice is a defence unless the practice was inherently defective.
4. An honest difference of opinion between competent practitioners as to which is the better of two alternative courses of treatment does not establish negligence.
5. It is for the plaintiff to prove negligence on the balance of probabilities; the burden does not shift to the practitioner simply because an adverse outcome occurred.

The sixth principle — sometimes folded into principles 2 and 3 — is the rationality rider: even where a practitioner followed approved general practice, that defence falls if the practice is one that no reasonable practitioner, taking ordinary care, would have followed. The principles work as a single test, not as separate gates. Morrissey reaffirmed the structure intact.

A widespread misconception arose from the High Court judgment that Cross J had imposed an "absolute confidence" standard on cytology screeners. The Supreme Court rejected that reading firmly. Clarke CJ explained that "absolute confidence" was not a separate legal test but a phrase derived from the English Court of Appeal decision in Penney, Palmer & Cannon v East Kent Health Authority [2000] Lloyd's Rep Med 41 summarising the evidence of competent practitioners in that case about what a screener should be able to say of a slide before reporting it negative. The phrase described the standard of approach the profession itself articulated; the legal test remained Dunne.

Clarke CJ also addressed concerns raised by the cytology profession and by the medical community more broadly that a finding of negligence in Morrissey would impose a perfection standard on screening programmes. The Court was explicit that it does not. At paragraph 2.3 the Chief Justice noted that a clear smear followed by a later cancer diagnosis cannot itself establish negligence: there are several non-negligent reasons why this can happen, including the random distribution of abnormal cells across a slide, the time interval between testing and disease progression, and the hindsight bias inherent in audit re-examination.

In subsequent paragraphs of the Supreme Court judgment, Clarke CJ addressed how Cross J had used the English Court of Appeal authority Penney, Palmer & Cannon v East Kent Health Authority [2000] Lloyd's Rep Med 41. The Chief Justice characterised the English authority as a synopsis of the evidence given by competent practitioners in that case — not as a separate legal test that Cross J could be said to have imported into Irish law. The cytology profession's own articulation of what a screener should be able to say of a slide before reporting it clear is an evidential standard the profession sets for itself. The legal test by which negligence is assessed against that evidential standard remains the Dunne test. A practitioner reading Morrissey for the first time is well advised to treat the phrase "absolute confidence" as a witness characterisation, not as judicial doctrine.

Issue 2 — Sufficiency of Reasoning Regarding Quest Diagnostics Copy link

Quest had argued that the trial judge's reasoning on the 2009 slide fell below the "irreducible minimum" of judicial reasoning that an appellate court could review. The Supreme Court rejected that argument. Although the High Court judgment did not separately address every point of expert disagreement, it laid out the competing evidence, identified which expert evidence it preferred, and explained why on the central question (whether a reasonably competent screener applying the profession-defined standard would have identified the abnormalities on the 2009 slide). That was sufficient.

This holding has practical effect in subsequent screening litigation: a trial judge does not need to micro-justify every evidential preference where the central reasoning is intelligible. It also reduced the appellate target for laboratories defending screening claims; the Supreme Court has signalled that High Court fact-finding on screening adequacy will receive respect on appeal provided the core reasoning is articulated.

Issue 3 — Sufficiency of Reasoning Regarding Medlab Pathology Copy link

Medlab raised the same challenge in respect of the 2012 slide and lost on the same basis. The Court drew a careful distinction between the adequacy of the screen itself (the cytotechnologist's reading) and the adequacy of the report's review process (the senior cytologist's verification). Cross J had found Medlab negligent on the screening adequacy point, and the Supreme Court found his reasons sufficient. The factual question of whether the 2012 slide displayed abnormalities a competent screener should have identified was for the trial judge; it was not an appellate question.

Issue 4 — Vicarious Liability Overturned; Non-Delegable Duty Confirmed Copy link

This issue produced the most consequential doctrinal expansion. Cross J had held the HSE vicariously liable for the laboratories on the basis that, although Quest and Medlab were independent contractors, the relationship was sufficiently close to attract vicarious liability. The Supreme Court reversed that finding. Vicarious liability in Irish tort law is not imposed on a defendant for the wrongs of an independent contractor where the contractor exercises genuine independence; both laboratories did.

The Supreme Court then turned to the alternative basis on which Cross J had also found the HSE liable: a non-delegable duty of care owed by the HSE itself directly to women who participated in CervicalCheck. Clarke CJ upheld this finding. The Court adopted the analytical framework of the United Kingdom Supreme Court in Woodland v Essex County Council [2013] UKSC 66, where Lord Sumption identified the circumstances in which a primary, non-delegable duty arises. The five Woodland criteria and how each was satisfied on the Morrissey facts are set out below.

Each of the Woodland factors was satisfied in Morrissey. The HSE had adopted, designed, and publicly promoted the CervicalCheck programme. Women who provided smear samples did so on the basis that the HSE had assumed responsibility for the screening service. The HSE delegated the cytology reading to private laboratories, but it could not contract out of its assumed responsibility. The non-delegable duty therefore existed and had been breached by the laboratories' negligence.

The practical consequence is that the HSE remains the primary defendant in any post-Morrissey screening claim arising from any of the national screening programmes — CervicalCheck, BreastCheck, BowelScreen, and Diabetic RetinaScreen — even where the alleged negligence was performed by an external contractor. The HSE bears the burden of explaining how its outsourcing arrangements preserved the standard of care it had assumed by adopting and promoting the screening service.

Issue 5 — General Damages and Loss-of-Services Copy link

Cross J had awarded Mrs Morrissey €500,000 in general damages for pain and suffering, and a separate sum to Mr Morrissey for the value of household services his wife would otherwise have provided over her notional life expectancy. The High Court had also separately awarded €10,000 in nominal damages against the HSE for its failure to disclose the 2014–2015 audit findings to Mrs Morrissey for almost four years. The nominal damages were doctrinally distinct from the cytology-negligence award: they recognised a separate cause of action against the HSE for the disclosure failure itself, treated as a breach of the duty of candour owed to a patient who had been the subject of an audit revealing earlier diagnostic error. The Supreme Court did not disturb the €10,000 award. The Supreme Court was asked to consider both the general damages and the loss-of-services elements.

On general damages, the Court confirmed that €500,000 represented, in March 2020, the appropriate maximum for general damages in the most serious personal-injury cases. The figure was a continuation of the judicial cap doctrine traced from Sinnott v Quinnsworth [1984] ILRM 523 (where the Supreme Court fixed the original limit at IR£150,000) through Yun v MIBI [2009] IEHC 318 (where the High Court applied an inflation-adjusted figure of around €450,000).

That €500,000 figure has since been displaced in practice by the statutory bracket in the Personal Injuries Guidelines adopted by the Judicial Council under section 7 of the Judicial Council Act 2019. The Guidelines took effect on 24 April 2021 and set €550,000 as the upper bracket for catastrophic injuries. On 31 January 2025 the Judicial Council voted to approve draft amendments to the Guidelines uplifting awards by 16.7% on average, which would have raised the catastrophic bracket to approximately €642,000. The draft amendments were submitted to the Minister for Justice on 4 February 2025. In July 2025 the Government decided not to bring the proposed uplift before the Oireachtas for approval, with the result that the 16.7% uplift has not taken effect and will not do so unless and until that decision is revisited. The operative bracket therefore remains €550,000 in May 2026.

On the loss-of-services award, the Supreme Court allowed Medlab's appeal. Cross J had compensated Mr Morrissey directly for the value of his wife's domestic and child-care contributions over the period she would have lived had she not been misdiagnosed. The Supreme Court held that under section 48 of the Civil Liability Act 1961, an action of that kind — for dependency on the deceased — lies only after the injured person has died, and only at the suit of the statutory dependants in a fatal-injuries action.

"Where the death of a person is caused by the wrongful act of another such as would have entitled the party injured, but for his death, to maintain an action and recover damages in respect thereof, the person who would have been so liable shall be liable to an action for damages for the benefit of the dependants of the deceased."

Section 48(1), Civil Liability Act 1961 — irishstatutebook.ie

A living plaintiff cannot recover prospective dependency losses on behalf of a surviving spouse during her own lifetime.

Clarke CJ described this as "potentially anomalous" and noted that the appropriate forum for any reform was the Oireachtas. As of May 2026, no amendment to section 48 has been brought forward. The practical effect is that a terminally ill claimant who wishes to secure the future value of services for her family must in some cases discontinue the personal-injury proceedings and rely on the estate pursuing a dependency claim under section 48 after death. This is a difficult procedural and ethical position the case law has identified but the legislature has not yet resolved.

Paragraph Reference Matrix — Where to Find Each Holding in the Judgment Copy link

Each major holding in Morrissey v HSE [2020] IESC 6 can be located in the judgment by paragraph. The matrix below maps each doctrinal point to its paragraph pinpoint to support precise citation in submissions, articles, and practitioner notes. References are to the unanimous judgment of Clarke CJ.

Verification note: Paragraph pinpoints [2.3] and [6.32] are confirmed verbatim across multiple secondary sources (Lexology, Irish Legal News, Fieldfisher). The [6.33]–[6.35] reference for Penney Palmer characterisation is approximate and sourced from secondary commentary; the precise paragraph range may differ. Items described as "section on..." reflect where the holding appears thematically in the judgment rather than a specific paragraph number. Practitioners citing in court papers should verify the paragraph against the primary source on BAILII or the courts.ie official PDF.

In the Court's Own Words — Key Passages and Verified Phrases Copy link

The four short passages below capture the operative reasoning of the Supreme Court in Morrissey v HSE [2020] IESC 6, together with the underlying Dunne formulation it reaffirmed and the statutory provision that disposed of the loss-of-services question. The first and last are verbatim from the primary sources; the middle two summarise Clarke CJ's reasoning with short verbatim phrases highlighted in quotation marks. The full judgment text is available on BAILII and from courts.ie.

"The true test for establishing negligence in diagnosis or treatment on the part of a medical practitioner is whether he has been proved to be guilty of such failure as no medical practitioner of equal specialist or general status and skill would be guilty of if acting with ordinary care."

Finlay CJ in Dunne v National Maternity Hospital [1989] IR 91 at p.109 — the formulation reaffirmed by the Supreme Court in Morrissey v HSE [2020] IESC 6

"Where the death of a person is caused by the wrongful act of another such as would have entitled the party injured, but for his death, to maintain an action and recover damages in respect thereof, the person who would have been so liable shall be liable to an action for damages for the benefit of the dependants of the deceased."

Section 48(1), Civil Liability Act 1961 — the statutory provision that disposed of the loss-of-services question in Morrissey

Why Morrissey v HSE Matters Copy link

Morrissey is the controlling authority on five connected questions of Irish medical-negligence law. It reaffirms the Dunne test as the sole standard of care, distinguishes that legal standard from the profession's own "standard of approach", expands non-delegable duty doctrine into the public-screening context, confirms the judicial cap on general damages, and identifies a statutory lacuna on loss-of-services awards that remains unresolved.

The case is also a landmark for outsourced public-health services. The non-delegable duty doctrine adopted from Woodland now operates as the route by which the State Claims Agency, acting for the HSE, accepts primary liability in CervicalCheck, BreastCheck, BowelScreen, and Diabetic RetinaScreen litigation — even where the cytology, radiology, or endoscopy was performed by an external contractor. That allocation of liability has shaped settlement strategy and indemnity arrangements between the State and contracted providers since 2020.

A practitioner-experience point worth surfacing: the practical effect of the non-delegable duty route is that the HSE typically appears as the primary named defendant on the settlement instrument in post-Morrissey screening claims. Internal indemnity claims between the HSE (via the State Claims Agency) and the contracted laboratories then proceed separately, often confidentially. For a plaintiff, this is favourable. It preserves the State as the responsible party for purposes of payment and apology, avoids the procedural complexity of pursuing a foreign-domiciled laboratory (Quest was Michigan-based), and reinforces the broader policy that public services adopted and promoted by the State should remain accountable at the State level even when operationally delegated.

From a doctrinal perspective, Clarke CJ's framing of non-delegable duty as "a potentially developing area of primary liability" has been read by Irish practitioners as an invitation to test the boundaries of the doctrine in other contexts: outsourced diagnostic services under the National Treatment Purchase Fund, contracted-out community-care arrangements, and other situations in which a public body adopts and promotes a service while delegating the operational performance.

In practice, post-Morrissey screening claims now turn on a narrower factual question than they did before 2020. The Dunne test has not changed, but the route to HSE liability is settled — the HSE is the primary defendant by virtue of the non-delegable duty, and the litigation focuses on whether the cytologist's reading of the slide met the standard of approach the profession set for itself. A nuance the headnote does not capture is that the HSE's assumed responsibility flows from its adoption and promotion of the screening programme, not from its operational role: a public body that runs a screening service quietly, without promotion, would face a harder argument that the same non-delegable duty arose.

Subsequent Treatment of Morrissey v HSE Copy link

Three reported applications of Morrissey have shaped its meaning in 2023–2025: Mitchell v HSE, Germaine v Day, and Perez v Coombe Women and Infants University Hospital. Each is discussed below; the practical effect for the post-Morrissey doctrine is captured in the treatment table beneath.

Mitchell v HSE [2023] IEHC 394 — No Duty to Relatives Copy link

In Mitchell v HSE [2023] IEHC 394, O'Connor J of the High Court confirmed that the duty of care recognised in Morrissey does not extend to relatives of a person who participated in a national screening programme. The plaintiffs in Mitchell were the parents of a deceased woman who had participated in CervicalCheck and who died of metastatic cervical cancer in April 2015; they sought damages for nervous shock and mental distress arising from her diagnosis and death. Cross J in the High Court below in Morrissey had already held that no duty of care is owed by screening services to relatives — and the Supreme Court did not disturb that holding. O'Connor J in Mitchell revisited that holding in detail and applied the same reasoning: even if reasonable foreseeability and proximity were established, public-policy considerations militate against extending the screening duty beyond the screened individual. Practitioners typically encounter this in attempted relative-led nervous-shock claims arising from a screening failure that caused the index patient's death; the route forward in such cases is a fatal-injuries action under section 48 of the Civil Liability Act 1961 by the statutory dependants, not a primary tort claim by the relative.

Germaine v Day [2024] IEHC 420 — Nervous Shock Boundaries Reaffirmed Copy link

In Germaine v Day [2024] IEHC 420, Egan J of the High Court applied Morrissey and Mitchell in dismissing a widow's nervous-shock claim arising from her husband's delayed cancer diagnosis. The Court held that the gradual decline of a spouse from a misdiagnosed disease does not constitute the "sudden shocking event" required by the five-part Kelly v Hennessy [1995] 3 IR 253 test for nervous shock, and that in any event the diagnostic service did not owe the secondary victim a duty of care. The combined effect of Morrissey, Mitchell, and Germaine is that relatives of a misdiagnosed patient face a difficult threshold in any post-2024 nervous-shock claim: they must establish both a sudden shocking event (which a gradual decline is not) and a duty of care running to the secondary victim (which the diagnostic relationship typically does not create).

Perez v Coombe [2025] IEHC 396 — Dunne Reaffirmed Over Clinical Guidelines Copy link

In Gimenez Perez v Coombe Women and Infants University Hospital & ors [2025] IEHC 396, Egan J applied Morrissey in the obstetric context. Ms Perez had delivered her second child at the Coombe in October 2019 and developed a primary postpartum haemorrhage immediately after delivery, managed conservatively; she later attended Midland Regional Hospital, Portlaoise in November 2019 with a secondary postpartum haemorrhage attributed to retained products of conception, and ultimately underwent surgical evacuation in December 2019. The plaintiff's case leaned heavily on clinical guidelines, arguing that escalation triggers had been missed by both hospitals. The Court rejected that approach: clinical guidelines inform but do not displace the Dunne test, and a "two-schools-of-thought" defence remains available where a body of competent practitioners would have taken a different approach. Both conservative and surgical management of the secondary PPH were accepted as valid schools of thought supported by expert evidence. Perez is therefore the post-2020 confirmation that Morrissey's reaffirmation of Dunne governs medical-negligence claims across specialties — not only screening programmes — and that adherence to a clinical guideline is not in itself determinative of either liability or compliance with the legal standard of care.

Common Misconceptions About Morrissey v HSE Copy link

Four widespread misreadings of Morrissey v HSE [2020] IESC 6 recur in commentary and informal summaries. Each is set out below as a myth-and-reality pair with the controlling source. The judgment itself rejects each misreading either expressly or by necessary implication.

The Dunne Test and Bolam/Bolitho — A Jurisdictional Comparison Copy link

Both Morrissey and the Irish position generally are sometimes confused with the English Bolam/Bolitho framework. The two tests are different and the difference matters in cross-border practice.

For cross-border claims — for example, where a diagnostic procedure is performed at a laboratory in Northern Ireland or England with samples taken in Ireland — the jurisdiction of the negligent act ordinarily dictates the applicable test. Where doubt exists, conflict-of-laws analysis under Regulation (EC) 864/2007 (Rome II) applies. For the purposes of all Irish-jurisdiction claims, including all national screening claims, the Dunne test as reaffirmed in Morrissey governs. The English authorities are persuasive only.

Open Doctrinal Questions After Morrissey v HSE Copy link

Morrissey v HSE resolved five questions but opened, or left open, several others that practitioners are likely to test in the next decade. Each is summarised below with the doctrinal pressure point it identifies.

1. Non-delegable duty beyond national screening programmes. Clarke CJ described the doctrine as "a potentially developing area of primary liability". The boundary of the duty has not been litigated outside the four established screening programmes. Whether it extends to outsourced diagnostic services under the National Treatment Purchase Fund, contracted-out community mental-health assessment, or hospital-laboratory outsourcing arrangements remains untested. A future case will need to address how publicly an adopted-and-promoted service must be to attract the Woodland-derived duty.
2. The section 48 loss-of-services lacuna. Clarke CJ described the loss-of-services position as "potentially anomalous" and identified the Oireachtas as the appropriate forum for reform. No Bill amending section 48 of the Civil Liability Act 1961 has been brought forward as of May 2026. A terminally ill claimant who wishes to secure the future value of services for her family must in some cases discontinue her personal-injury proceedings and rely on the estate pursuing a dependency claim under section 48 after death. Whether the courts can revisit this through equitable doctrine, or whether the lacuna will require legislation, is unresolved.
3. The civil-liability consequences of a Part 2 Patient Safety Act breach. The Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 converted the 2013 HSE Open Disclosure Policy into a statutory duty. Part 2 of the Act makes mandatory open disclosure of notifiable incidents a legal obligation backed by criminal sanction (section 77). The €10,000 nominal damages award in Morrissey v HSE [2019] IEHC 268 reflected breach of the non-statutory 2013 policy. The independent tortious cause of action for breach of the statutory duty under Part 2 is not yet the subject of reported Irish case law. Whether substantive (not nominal) damages flow from a Part 2 breach is a question the first post-Act disclosure-failure case will need to answer.
4. The interaction between clinical guidelines and the Dunne test in specialties beyond obstetrics. Perez v Coombe [2025] IEHC 396 (Egan J) confirmed that clinical guidelines inform but do not displace the Dunne test in obstetrics. The same proposition should hold across specialties, but it has not been tested in oncology, emergency medicine, or psychiatry, where guideline compliance is increasingly relied on by defendants. A future Supreme Court application will likely settle this for cross-specialty practice.
5. Whether the leapfrog appeal route survives further appellate restructuring. Morrissey proceeded directly to the Supreme Court under Article 34.5.4° because of the matter's general public importance. Subsequent leapfrog grants under the same Article have been rare; whether the Supreme Court will continue to entertain leapfrogs in medical-negligence cases of national significance, or whether it will defer such cases to the Court of Appeal first, is a question the next CervicalCheck-scale dispute will test.

Morrissey v HSE in Practice — The 2026 Claim Pathway After Tribunal Dissolution Copy link

Two practical changes since the 2020 judgment have reshaped how Morrissey-derived claims now proceed: the dissolution of the CervicalCheck Tribunal on 30 January 2026, and the displacement of the Morrissey €500,000 cap by the €550,000 Personal Injuries Guidelines bracket.

The CervicalCheck Tribunal — Established 2020, Dissolved 2026 Copy link

The CervicalCheck Tribunal Act 2019 created a statutory tribunal designed to resolve CervicalCheck-related claims outside the High Court. The Tribunal was established on 27 October 2020 with the intention of providing a less adversarial process for women affected by the audit-disclosure failures highlighted in Morrissey. It did not work as intended. According to the Department of Health written reply to Dáil Question 32424/25 (June 2025) and the CervicalCheck Tribunal (Dissolution) Order 2026 (S.I. No. 19/2026), the Tribunal's lifetime performance was as follows.

The practical consequence is that as of 30 January 2026, all new CervicalCheck claims and all other national-screening-related medical-negligence claims proceed directly in the High Court. The State Claims Agency manages the defence on behalf of the HSE. Morrissey-derived doctrine — the Dunne standard plus the non-delegable duty — applies in every such case.

The General Damages Cap — From €500,000 to €550,000 to a Blocked €642,000 Copy link

The €500,000 cap upheld in Morrissey was the judicial cap as it stood in March 2020. Since 24 April 2021 the Personal Injuries Guidelines have applied a statutory bracket of €550,000 to catastrophic injuries. The cap-evolution timeline is set out below.

The operative position in May 2026 is that catastrophic personal-injury cases continue to attract a maximum general damages bracket of €550,000 under the current general damages bracket of €550,000. The €500,000 figure from Morrissey is historical; the €642,000 figure from the January 2025 Judicial Council vote has no legal effect.

The Patient Safety Act 2023 — Statutory Reform Traceable to Morrissey Copy link

The most consequential legislative reform traceable to the CervicalCheck disclosure failures highlighted in Morrissey is the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023. The Act was signed by the President on 2 May 2023 and commenced on 26 September 2024. It was developed in response to the Scally Scoping Inquiry into the CervicalCheck Screening Programme (2018) and the sustained advocacy of the 221+ Patient Support Group following Morrissey. Two parts matter for screening claims. Part 2 introduces mandatory open disclosure of specified notifiable incidents — listed in Schedule 1 of the Act — a category that captures specified diagnostic errors causing death or serious harm. Where a notifiable incident occurs, the health-service provider must hold a notifiable-incident disclosure meeting with the patient (or relevant person), document the meeting, and provide a written statement. Section 77 makes failure to comply with the disclosure obligation, without reasonable excuse, a criminal offence. The 2014–2018 disclosure delay that Morrissey made notorious would today engage the Part 2 obligations.

The doctrinal lineage of open disclosure in Ireland runs from the HSE's Open Disclosure Policy adopted in 2013, through the voluntary scheme established by Part 4 of the Civil Liability (Amendment) Act 2017, and finally to the mandatory regime in Part 2 of the 2023 Act. The €10,000 nominal damages award against the HSE in Morrissey v HSE [2019] IEHC 268 was for the breach of the 2013 HSE policy — at that time a non-statutory obligation, breach of which sounded only in nominal damages because there was no recognised independent tortious cause of action for non-disclosure. The 2023 Act converts that policy obligation into a statutory duty backed by criminal sanction, opening at least the possibility of substantive damages for future non-disclosure failures, though the precise civil-liability consequences of breaching the Part 2 duty are not yet the subject of reported Irish case law.

Part 5 of the Act creates a statutory right for patients to request a review of their previous results in the three national cancer screening programmes: CervicalCheck, BreastCheck, and BowelScreen. The review is independent of the screening programme itself and produces a written report the patient may share with her legal advisers. For practitioners building a screening-negligence case, a Part 5 review report is now an early evidence asset that did not exist when Morrissey was litigated. A nuance the official Act text does not capture is that the Part 5 right complements but does not replace the discovery rights available in litigation: a Part 5 report can be obtained without issuing proceedings, but original slide images and laboratory worksheets are still typically secured through pre-action correspondence or formal discovery.

Frequently Asked Questions Copy link

Glossary — Key Terms Used in Morrissey v HSE Copy link

The five terms below appear repeatedly in the Morrissey v HSE judgment and in the case-law commentary surrounding it. Short, technically accurate definitions for each are set out below.

Non-delegable duty

A primary duty of care owed by the defendant directly to the claimant that cannot be discharged by delegating performance to a third party. The defendant remains liable for the contractor's negligence in performing the delegated function. The Morrissey Supreme Court held that the HSE owes such a duty to women in CervicalCheck.

Leapfrog appeal

A direct appeal from the High Court to the Supreme Court, bypassing the Court of Appeal, under Article 34.5.4° of the Constitution (added by the Thirty-third Amendment, 2013). Permitted only where the Supreme Court is satisfied that the case involves a matter of general public importance or where an appeal is necessary in the interests of justice. The Morrissey leave-to-appeal grant is reported as Morrissey v HSE [2019] IESC 60.

Standard of approach

The technique, protocol, or evidential threshold the medical profession itself sets for performing a clinical task — for example, the level of certainty a cytology screener must have of a slide before reporting it clear. It is an evidential standard given by experts. It is not the legal standard of care, which in Ireland is the Dunne test.

Ratio decidendi

The legal reasoning essential to the court's decision — the principle of law on which the case turns. In Morrissey, the ratio includes the reaffirmation of Dunne, the rejection of "absolute confidence" as a separate test, the establishment of the non-delegable duty for CervicalCheck, and the section 48 limitation on loss-of-services awards.

Obiter dictum

A judicial observation made "by the way" — not part of the ratio and therefore not binding on later courts. Clarke CJ's characterisation of the section 48 loss-of-services position as "potentially anomalous" is obiter; it does not change the law but signals that the Court considered the position open to legislative review.

How to Cite Morrissey v HSE in Academic and Legal Writing Copy link

The standard citation forms for Morrissey & anor v Health Service Executive & ors [2020] IESC 6 are set out below for the four most common citation conventions encountered in Irish legal writing and academic work.

For court submissions, the neutral citation is sufficient; pinpoint references (e.g. Morrissey v HSE [2020] IESC 6, [6.32]) should be used wherever the argument turns on a specific passage. For academic writing under OSCOLA, the unreported neutral citation is the preferred form; the BAILII URL is included only in the bibliography or in a footnote on first citation.

Related Cases and Resources Copy link

• Doctrinal parents: Dunne v National Maternity Hospital [1989] IR 91 (the test); Sinnott v Quinnsworth [1984] ILRM 523 (the cap doctrine).
• Subsequent applications: Mitchell v HSE [2023] IEHC 394; Germaine v Day [2024] IEHC 420; Perez v Coombe [2025] IEHC 396.
• Persuasive UK authority adopted: Woodland v Essex County Council [2013] UKSC 66 (non-delegable duty framework).
• Statutes engaged: Civil Liability Act 1961, s.48; Statute of Limitations (Amendment) Act 1991, s.2; CervicalCheck Tribunal Act 2019; Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023; S.I. No. 19/2026.
• Internal resources: cervical screening negligence claims · cancer misdiagnosis · how to prove medical negligence · general damages · time limits · medical negligence (pillar).